Terms: = Ovarian cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Treatment
3 results:
1. Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database.
Morice PM; Leary A; Dolladille C; Chrétien B; Poulain L; González-Martín A; Moore K; O'Reilly EM; Ray-Coquard I; Alexandre J
Lancet Haematol; 2021 Feb; 8(2):e122-e134. PubMed ID: 33347814
[TBL] [Abstract] [Full Text] [Related]
2. EPIDEMIOLOGY AND MANAGEMENT OF ovarian cancer BASED ON THE CLINICAL EXPERIENCE OF THE SOUTHERN REGION OF UKRAINE.
Rybin A; Varabina A; Broshkov M
Georgian Med News; 2019 Mar; (288):32-36. PubMed ID: 31101771
[TBL] [Abstract] [Full Text] [Related]
3. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women.
Grattarola R
Am J Obstet Gynecol; 1973 Jun; 116(3):423-8. PubMed ID: 4707544
[TBL] [Abstract] [Full Text] [Related]
